Deviation Capital is a New York, New York-based venture capital firm. Value Add VC tracks 2 companies Deviation Capital has invested in and 1 venture round it took part in (1 as lead).
Deviation Capital key facts (as of )
| Fact | Value | Source |
|---|---|---|
| Headquarters | New York, New York, USA | SEC Form ADV (IAPD), September 16, 2026 |
| Type | Venture capital firm | Value Add VC classification |
| Funds tracked | 1 | Funds table on this page (each fund cites its source) |
| Venture rounds tracked | 1 (led 1, joined 0) 1 in the last 12 months | Recent deals table on this page (each round cites its source) |
| Portfolio companies tracked | 2 | Portfolio list on this page |
Recent deals we track
2Track record: led 1 and participated in 0 of 1 tracked venture round · 1 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Oct 24, 2026 | Bolt Biotherapeutics | acquisition | Participated | $120M | — | Deep Track CapitalunverifiedAndreessen HorowitzunverifiedEventide Asset ManagementunverifiedCasdin CapitalunverifiedDeviation CapitalunverifiedADAR1 CapitalLYFE CapitalCoastlands CapitalCurie.Bio+3 more | Pulse 2.0 |
| Jul 17, 2026 | Walden Robotics | funding round | Led | $300M | — | ToyotaLeadDeviation CapitalLead | Crunchbase News |
Is something wrong on this page?
We track Deviation Capital but have little verified detail yet.
Strategy
Funds
1| Fund | Vintage | Size | Strategy | Source |
|---|---|---|---|---|
| Deviation Capital Fund V | 2026 | target $300M | FlagshipData-driven early-stage · Early-stage |
Portfolio
2 totalSector / Stage Activity
Co-Investors
6Value Add Research
Latest Pulse
- Oct 25, 2026Bolt Biotherapeutics Buys Prana, Raises $120M For PRA-216Bolt Biotherapeutics acquired Prana Therapies in a stock-for-stock reverse merger and raised a concurrent $120 million private placement to advance Prana's lead bispecific antibody, PRA-216.→
- Jul 17, 2026Toyota Backs Walden Robotics' $300M Round at $1.1BGeneral-purpose robotics startup Walden Robotics raised $300 million at a $1.1 billion valuation with Toyota and Deviation Capital leading, another sign automakers are underwriting the humanoid and general-purpose robotics race directly.→
Deviation Capital FAQ
What companies has Deviation Capital backed?
Companies Value Add VC tracks as Deviation Capital investments include Bolt Biotherapeutics and Walden Robotics.
Where is Deviation Capital based?
Deviation Capital is headquartered in New York, New York, USA, according to SEC Form ADV (IAPD).
Who does Deviation Capital co-invest with most?
In the rounds Value Add tracks, Deviation Capital most often invests alongside Andreessen Horowitz (1 shared deal), Casdin Capital (1 shared deal), Deep Track Capital (1 shared deal), NextView Ventures (1 shared deal), Shine Capital (1 shared deal).
Sources & methodologyshow
- Crunchbase Newsresearch database1 fact
- Pulse 2.0Value Add VC data1 fact
- WSJ Pro (archived)Value Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.